Delivery Order SPE2DB22D1106-SPE2DB25FEQJ0
- Not listed
- The Defense Logistics Agency awarded a $1,455.99 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for VIMPAT 10 mg/mL Solution in 200 mL quantities. This firm fixed price order, with an ultimate completion date of August 4, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was awarded without a set-aside designation through competitive procurement, and performance will occur at the...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.32 to AmerisourceBergen Drug Corp for VIMPAT 10 mg/ml solution in 200ml quantities. This non-competitive delivery order, issued on August 14, 2025, represents a firm fixed-price procurement executed under a child contract arrangement with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,670.96 to AmerisourceBergen Drug Corp for VIMPAT 10 mg/mL solution (200 mL), a pharmaceutical product used in neurological treatment. This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The award carries no set-aside designation and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for VIMPAT 10 mg/ml solution in 200 ml quantities, with a ceiling value of $1,048.32. This is a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, awarded on September 3, 2025. The award carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of VIMPAT 10 mg/mL solution in 200 mL quantities, valued at $1,959.86. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of VIMPAT 10 mg/mL solution in 200 mL quantities, with a ceiling value of $1,646.10. The contract utilizes firm fixed pricing with an ultimate completion date of December 5, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,409.40 to AmerisourceBergen Drug Corp for VIMPAT 10 mg/ml solution in a 200 ml volume. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, completed on September 10, 2025, with an ultimate completion date of September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a $266,680 firm fixed price delivery order to Amerisourcebergen Drug Corporation for VIMPAT 10 MG/ML solution in 200ML bottles. As the prime contractor, Amerisourcebergen will deliver this pharmaceutical product to a facility in Conshohocken, Pennsylvania in support of the Defense Logistics Agency's medical supply chain responsibilities. No subcontractors or set aside designations were indicated. The delivery order was issued under an existing DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of VIMPAT 10 mg/mL solution in 200 mL quantities, valued at $1,844.01. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competitively awarded. VIMPAT (lacosamide) is an antiepileptic...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of VIMPAT 200 mg/20 ml vials valued at $1,365.00. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEQJ0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 28, 2025, for the supply of VIMPAT 10 mg/ml solution in a 200 ml quantity, valued at $1,964.65. This firm fixed-price delivery order, which is set to be completed by May 29, 2025, represents a pediatric or adjunctive treatment pharmaceutical for seizure management. The contract was competitively awarded with no set-aside designation and will be fulfilled from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. As a prime contract vehicle for global pharmaceutical support, the IDC enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs and other federal healthcare systems. This delivery order exemplifies the company's role as a critical pharmaceutical distributor supporting the Defense Health Agency and broader military medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 5/28/25 |